Qiming Venture Partners Portfolio Company WeRide Named to 2025 Wealth China Tech 50 List

Recently, the 2025 Wealth China Tech 50 list was officially unveiled. The list seeks out companies born in China that are shaping the world — their success lies not only in specific technologies and products, but in the innovative spirit and global vision they represent.

WeRide (NASDAQ: WRD), a Qiming Venture Partners portfolio company, made the list.

WeRide

Reason for inclusion: Autonomous driving technology has reached a critical stage, and WeRide is accelerating ahead. It is the only tech company in the world whose products hold autonomous driving permits in six countries — China, the United States, the UAE, Singapore, France, and Saudi Arabia — and it currently conducts R&D, testing, and operations in 30 cities across 10 countries. In October 2024, WeRide listed on Nasdaq, becoming the "first global general-purpose autonomous driving stock" and the "first global Robotaxi stock."

WeRide's technology covers smart mobility, smart logistics, and smart sanitation, and has entered the commercial operations stage. The company brings extensive practical experience both at home and abroad, and has established strategic partnerships with multiple top-tier global OEMs and Tier 1 suppliers.

---

At the intersection of technological iteration and market demand, Chinese companies are driving technology to market with formidable execution. In the large model space, they are optimizing vertical-domain models for finance, healthcare, and other sectors to boost efficiency. They are enabling machines to replace humans in high-risk, high-intensity work scenarios by improving joint flexibility and battery life. They are developing more efficient, cleaner energy sources to foster greater harmony between humanity and nature.

Source | Wealth Chinese Edition

Past Coverage

Qiming Stars | WeRide Launches 7×24 Hardcore Testing in Beijing Qiming Perspectives | Duane Kuang, Qiming Venture Partners: Now Is the Time for Chinese Tech to Go Global Qiming Stars | Six Qiming Venture Partners Portfolio Founders Named to Wealth China 40 Under 40 Business Elite List

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the NYSE, Nasdaq, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited via M&A and other means. More than 80 have become recognized unicorns or super-unicorns.

Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ: BILI, 09626.HK), Zhihu (NYSE: ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ: WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ: ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ: SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), Sinocelltech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.